23782473 | Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma. | World J Surg Oncol | 2013 Jun 19 | Zou Q | doi: 10.1186/1477-7819-11-143. |
27363653 | MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma. | J Surg Res | 2016 Jun 15 | Su BB | doi: 10.1016/j.jss.2016.03.021 |
20596667 | ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139. | Int J Oncol | 2010 Aug | Chay D | - |
30431082 | ERp57small interfering RNA silencing can enhance the sensitivity of drugresistant human ovarian cancer cells to paclitaxel. | Int J Oncol | 2019 Jan | Li S | doi: 10.3892/ijo.2018.4628 |
26772958 | Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies. | Transl Res | 2016 May | Caorsi C | doi: 10.1016/j.trsl.2015.12.013 |
24490732 | AGR2, ERp57/GRP58, and some other human protein disulfide isomerases. | Biochemistry (Mosc) | 2013 Dec | Shishkin SS | doi: 10.1134/S000629791313004X. |
26771192 | LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer. | PLoS One | 2016 Jan 15 | Basu A | doi: 10.1371/journal.pone.0146549 |
20035634 | Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer. | Mol Cancer | 2009 Dec 27 | Pressinotti NC | doi: 10.1186/1476-4598-8-130. |
23957851 | Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer. | Biomarkers | 2013 Nov | Chung H | doi: 10.3109/1354750X.2013.827742 |
27492604 | Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression. | Tumour Biol | 2016 Oct | Zhu Y | - |
23625662 | A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis. | Mol Cell Proteomics | 2013 Aug | Santana-Codina N | doi: 10.1074/mcp.M112.022772 |
25605256 | ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer. | Oncotarget | 2015 Feb 20 | Choe MH | - |
25081282 | Glucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell line. | BMC Cancer | 2014 Aug 1 | Liao CJ | doi: 10.1186/1471-2407-14-555. |
17188166 | Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. | Surgery | 2007 Jan | Leys CM | - |
26004124 | MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3. | Mol Med Rep | 2015 Sep | Zhao S | doi: 10.3892/mmr.2015.3826 |
26125904 | PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer. | Genet Mol Res | 2015 Jun 26 | Ramos FS | doi: 10.4238/2015.June.26.4. |
17456022 | The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems. | Curr Med Chem | 2007 | Khanal RC | - |
22266712 | Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro. | Anat Rec (Hoboken) | 2012 Mar | Lwin ZM | doi: 10.1002/ar.22413 |
19714814 | Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. | J Proteome Res | 2009 Apr | Cicchillitti L | - |